TY  - JOUR

T1  - Cost effectiveness of nusinersen for patients with infantile-onset spinal muscular atrophy in US

JO  - Cost Effectiveness and Resource Allocation

UR  - http://eprints.whiterose.ac.uk/167010/

PY  - 2020/10/06

AU  - Thokala P

AU  - Stevenson M

AU  - Kumar VM

AU  - Ren S

AU  - Ellis AG

AU  - Chapman RH

ED  - 

DO  - DOI: 10.1186/s12962-020-00234-8

PB  - Springer Science and Business Media LLC

VL  - 18

Y2  - 2024/12/22

ER  -